COURTNEY WESTON: Open Payments
NPI 1497901805 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,146 in 62 payments from 24 companies in 2025. Trend: 2023 $2,335 · 2024 $2,012 · 2025 $2,146
Food & beverage: $2,146
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $275 |
| Astellas Pharma US Inc | 6 | $202 |
| Abbott Laboratories | 2 | $199 |
| Amgen Inc. | 6 | $181 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $154 |
| Insulet Corporation | 1 | $124 |
| Novo Nordisk Inc | 2 | $119 |
| PFIZER INC. | 5 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Boston Scientific Corporation | 1 | $92 |
Products named: BREZTRI, Veozah, FREESTYLE LIBRE 3, Kerendia, Omnipod, Ozempic, OTEZLA, CAPLYTA.
Industry payments across LA — which companies pay providers there.
